Research

A new study from the College of Public Health, led by Professor Janusz Wojtusiak and Health Services Research doctoral candidate Ghaida Alsadah explores the use of machine learning to predict social isolation among caregivers of individuals with Alzheimer’s Disease and related disorders.

Professor John Cantiello reviews the literature to find out who is cheating, how, and how to head it off

Professor Farrokh Alemi receives NIH grant to pilot first-of-its-kind, evidence-based artificial intelligence tool to address the medication needs of Black and African American people with depression. This is part of the college’s Innovate for Good story series. 

MeAgainMeds.com, a free AI-powered website, helps clinicians more effectively match patients with the optimal antidepressant using big data.

Interprofessional research study from George Mason University found that family caregivers of older adults living with dementia experienced a 15% drop in stress after a 9-week online peer support program  

Researchers, led by associate professor Debora Goldberg, spoke with clinicians to better understand what causes burnout and discuss strategies to improve clinician well-being.

With the grant,College of Public Health professor Y. Alicia Hong and an interdisciplinary team aim to improve caregiving skills, reduce social distress, and improve quality of life for caregivers. 

Professor of Nursing Rebecca Sutter, along with faculty and students across colleges, will lead the creation of an interprofessional Learning Laboratory for Community Health.   

Patricia Tran became interested in health informatics while working as a nurse. She is now pursuing a Master of Health Informatics degree at Mason, where she obtained an internship with Commonwealth Cyber Initiative (CCI) over the summer to research how 5G-enabled technology can transform telehealth care.

In a recent study, George Mason University Associate Professor Hong Xue, PhD and colleagues evaluated the impact of ending market exclusivity for brand-name statin drugs. The first study to comprehensively assess the economic impact of generic competition for statins found that ending market exclusivity for statins saves U.S. $12 billion and individuals nearly $1,000 annually.